582 results on '"Kunert, Renate"'
Search Results
2. An engineering strategy to target activated EGFR with CAR T cells
3. Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens
4. Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation
5. Eukaryotic Expression Systems for Upstream Processing of Monoclonal Antibodies
6. Inefficient CAR-proximal signaling blunts antigen sensitivity
7. Impact of temperature and pH on recombinant human IgM quality attributes and productivity
8. Interaction Studies of Hexameric and Pentameric IgMs with Serum-Derived C1q and Recombinant C1q Mimetics.
9. Eukaryotic Expression Systems for Upstream Processing of Monoclonal Antibodies
10. Differential gene expression of a feed-spiked super-producing CHO cell line
11. Germinality does not necessarily define mAb expression and thermal stability
12. 76 C1q-IgM interaction studies with recombinant globular C1q variants
13. Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
14. Analysis of Product Quality of Complex Polymeric IgM Produced by CHO Cells
15. Screening of Media Supplements for High-Performance Perfusion Cultures by Design of Experiment
16. Multiple reaction monitoring targeted LC-MS analysis of potential cell death marker proteins for increased bioprocess control
17. Recombinant Human CD19 in CHO-K1 Cells: Glycosylation Patterns as a Quality Attribute of High Yield Processes
18. Supplementary Figure Legends and Supplementary Figures 1 through 5 from Generation of a Canine Anti-EGFR (ErbB-1) Antibody for Passive Immunotherapy in Dog Cancer Patients
19. Supplementary Table 1 from Generation of a Canine Anti-EGFR (ErbB-1) Antibody for Passive Immunotherapy in Dog Cancer Patients
20. Supplemementary Materials and Methods from Generation of a Canine Anti-EGFR (ErbB-1) Antibody for Passive Immunotherapy in Dog Cancer Patients
21. Data from Generation of a Canine Anti-EGFR (ErbB-1) Antibody for Passive Immunotherapy in Dog Cancer Patients
22. Biphasic cultivation strategy to avoid Epo-Fc aggregation and optimize protein expression
23. Introduction of germline residues improves the stability of anti-HIV mAb 2G12-IgM
24. Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
25. Approaches for Humanization of an Anti-idiotypic Murine Monoclonal Antibody
26. The Neutralizing Anti-HIV Antibody 2G12
27. Characterization of an Anti-Idiotypic Antibody Blocking the Capacity of the HIV-1 Specific nMAb 2F5
28. Novel human renal proximal tubular cell line for the production of complex proteins
29. Stable overexpression of miR-17 enhances recombinant protein production of CHO cells
30. Cloning of Single-Chain Antibody Variants by Overlap-Extension PCR for Evaluation of Antibody Expression in Transient Gene Expression
31. Transcription Profiling of Different Recombinant CHO Clones Based on Cross-species Microarray Analysis
32. Advances in recombinant antibody manufacturing
33. Production of Immunoglobulins and Monoclonal Antibodies Targeting Infectious Diseases
34. Continuous Perfusion versus Discontinuous Fed-Batch : Production of a ‘Cytotoxic ‘Glycoprotein in Protein-Free CHO Suspension Cultures
35. Benchmarking of commercially available CHO cell culture media for antibody production
36. Evaluating the bottlenecks of recombinant IgM production in mammalian cells
37. Upstream and downstream processing of recombinant IgA
38. Recombinant Fab expression and secretion in Escherichia coli continuous culture at medium cell densities: Influence of temperature
39. Biophysical Characterization of the Oligomeric States of Recombinant Immunoglobulins Type-M and Their C1q-Binding Kinetics by Biolayer Interferometry
40. Expression of Antibody Fragments with a Controlled N-Glycosylation Pattern and Induction of Endoplasmic Reticulum-Derived Vesicles in Seeds of Arabidopsis
41. SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year
42. Accurate comparison of antibody expression levels by reproducible transgene targeting in engineered recombination-competent CHO cells
43. Identification of microRNAs specific for high producer CHO cell lines using steady-state cultivation
44. In search of expression bottlenecks in recombinant CHO cell lines—a case study
45. Functional Trimeric SARS-CoV-2 Envelope Protein Expressed in Stable CHO Cells
46. Biophysical characterization of the oligomeric states of recombinant Immunoglobulins type-M and their C1q binding kinetics by Biolayer Interferometry
47. Transgene copy number comparison in recombinant mammalian cell lines: critical reflection of quantitative real-time PCR evaluation
48. Exploration of BAC versus plasmid expression vectors in recombinant CHO cells
49. The kinetic of SARS-CoV-2 antibody (Ab) decline determines the threshold for Ab persistence up to one year
50. Shake tube perfusion cell cultures are suitable tools for the prediction of limiting substrate, CSPR , bleeding strategy, growth and productivity behavior
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.